Eye cream with long-acting under-eye puffiness and wrinkle removing effects and preparation method thereof

Abstract

The invention discloses an eye cream with long-acting under-eye puffiness and wrinkle removing effects and a preparation method thereof, and relates to the technical field of eye creams. The eye cream provided by the invention comprises a water-phase component, an oil-phase component, a thickening agent component, a humectant component, a film-forming agent component, an antioxidant component and an auxiliary agent, and the specific raw materials and proportions of the components are regulated and controlled, so that the prepared eye cream can inhibit the activity of elastinase, plays a role in tightening the skin, and can be used for preparing the eye cream. The long-acting eye bag removing effect is also achieved.

Description

Technical Field

[0001] The invention relates to the technical field of eye creams, and in particular to an eye cream with long-lasting eye bag and wrinkle removing effects and a preparation method thereof. Background Art

[0002] The skin around the eyes is one of the thinnest parts of the human body. It is delicate and fragile, and is also the most active part. When the hydrolipid film of the eye skin lacks moisture and oil secretion, the collagen tissue tends to lose elasticity, and the eye skin gradually forms eye wrinkles due to relaxation. Once eye wrinkles appear, they are difficult to eliminate. Eye cream is a skin care product used to care for the skin around the eyes. It not only has the effect of moisturizing, but also can relieve problems such as dark circles and eye bags. It also has the effect of improving wrinkles and fine lines.

[0003] However, currently available eye creams are difficult to achieve immediate and long-lasting effects of removing eye bags and wrinkles, and do not have a good on-site demonstration effect.

[0004] In view of this, the present invention is proposed. Summary of the invention

[0005] The present invention aims to provide an eye cream with long-lasting eye bag and wrinkle removing effects and a preparation method thereof, aiming to provide an eye cream with immediate and long-lasting eye bag and wrinkle removing effects.

[0006] The present invention is achieved in that: In a first aspect, the present invention provides an eye cream with long-lasting eye bag and wrinkle removal effects, comprising, by mass percentage: 40%-80% of a water phase component, 5%-30% of an oil phase component, 3%-10% of a thickener component, 1.0%-5.0% of a moisturizer component, 1%-8% of a film-forming agent component, 0.2%-1.0% of an antioxidant component, and 5.0%-15.0% of an auxiliary agent; The oil phase component is DOWSIL™ 9509 Silicone Elastomer Suspension; The thickener components include magnesium aluminum silicate (VEEGUM HS) 1%-10% and sodium alginate 1%-5%.

[0007] In an optional embodiment, the composition comprises, by mass percentage: 50%-70% aqueous phase component, 10%-20% oil phase component, 5.0%-6.0% thickener component, 2.0%-3.0% moisturizer component, 2%-5% film former component, 0.3%-0.8% antioxidant component and 7.0%-9.0% auxiliary agent; The thickener component includes 2%-4% magnesium aluminum silicate and 1.0%-4.0% sodium alginate; Preferably, the aqueous phase component is water.

[0008] In an optional embodiment, the moisturizer includes: hexylene glycol 0.3%-1.0%, glycerin 0.1%-3.5%, betaine 0.1%-1.0% and macromolecular HA 0.001%-0.1%; Among them, the molecular weight of large molecule HA is 1.5-2 million.

[0009] In an alternative embodiment, the film former is PEPHA®-TIGHT CB.

[0010] In an optional embodiment, the antioxidant component is cinnamon.

[0011] In an optional embodiment, the adjuvant includes: sodium silicate 0.1%-6%, PEG-40 hydrogenated castor oil 0.04%-2%, menthyl lactate 0.01%-0.5%, lactic acid 0.1%-6%, PERFELINE®-FIT 0.1%-5%, VETIVYNE 0.1%-3% and ADEKA MEVALONOLACTONE 0.01%-0.2%.

[0012] In an optional embodiment, it also includes: pigment 0.02%-2.75%, preferably 0.15%-0.40%; Preferably, the pigment comprises: 0.01%-1.5% red iron oxide and 0.01%-1.25% yellow iron oxide.

[0013] In a second aspect, the present invention provides a method for preparing an eye cream according to any one of the aforementioned embodiments, comprising: preparing ingredients according to the composition of the eye cream, and mixing the components.

[0014] In an optional embodiment, the method includes: first mixing water and a thickener component and heating them to obtain a first material; mixing the first material with a moisturizer component and an antioxidant component, and then mixing them with an auxiliary agent, an oil phase component, and a film-forming agent component to obtain a second material; and mixing the second material with the ground pigment.

[0015] In an optional embodiment, it includes: Pretreatment: The pigments were mixed and ground with glycerin before adding, menthyl lactate was dissolved with PEG-40 hydrogenated castor oil before adding, and sodium silicate was dissolved with water before adding; Prepare the first material: mix water and magnesium aluminum silicate and heat to 80°C-85°C, then mix with sodium alginate and homogenize; Prepare the second material: mix the first material with glycerin, cinnamaldehyde, hexylene glycol, betaine, and macromolecular HA, then mix with lactic acid, and then add dissolved sodium silicate to mix and homogenize; after cooling to 40°C-50°C, mix with DOWSIL™ 9509 Silicone Elastomer Suspension and menthyl lactate pre-dissolved with PEG-40 hydrogenated castor oil, and then mix with PEPHA®-TIGHT CB, PERFELINE®-FIT, VETIVYNE, and ADEKA MEVALONOLACTONE; Mix the pigment: Mix the second material with the pigment that has been pre-ground with glycerin.

[0016] The present invention has the following beneficial effects: the eye cream provided by the present invention comprises a water phase component, an oil phase component, a thickener component, a moisturizer component, a film-forming agent component, an antioxidant component and an auxiliary agent. By regulating the specific raw materials and proportions of each component, the prepared eye cream can inhibit the activity of elastase, play a role in tightening the skin, and also has a long-lasting effect of removing eye bags. DETAILED DESCRIPTION

[0017] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0018] The embodiment of the present invention provides an eye cream with long-lasting eye bag and wrinkle removing effects, which comprises, by mass percentage, 40%-80% of an aqueous phase component, 5%-30% of an oil phase component, 3%-10% of a thickener component, 1.0%-5.0% of a moisturizer component, 1%-8% of a film-forming agent component, 0.2%-1.0% of an antioxidant component, and 5.0%-15.0% of an auxiliary agent.

[0019] The aqueous phase component can be pure water, and the mass fraction can be 40.000%, 45.000%, 50.000%, 55.000%, 60.000%, 65.000%, 70.000%, 75.000%, 80.000%, etc.

[0020] The oil phase component plays the role of replenishing skin oil and moisturizing the skin, and its mass fraction can be 5.0%, 10.0%, 15.0%, 20.0%, 25.0%, 30.0%, etc. The oil phase component can be DOWSIL™ 9509 Silicone Elastomer Suspension, which can be combined with other components to achieve a better wrinkle removal effect. Specifically, DOWSIL™ 9509 Silicone Elastomer Suspension is 60.9% polydimethylsiloxane / vinyl polydimethylsiloxane crosspolymer, 35% water, 0.2% methylparaben, 3% C12-14 parathion-12, 0.15% chlorphenesin, 0.5% phenoxyethanol, 0.25% benzoic acid, purchased from DOW.

[0021] The thickener component can make the product shape better, make the functional ingredients work better, and enhance the wrinkle removal effect. The mass fraction of the thickener component can be 3%, 5%, 8%, 10%, etc.

[0022] In some embodiments, the thickener component includes 1%-10% magnesium aluminum silicate (VEEGUM HS) and 1%-5% sodium alginate, preferably, 2%-4% magnesium aluminum silicate (VEEGUM HS) and 1.0%-4.0% sodium alginate. By optimizing the components of the thickener and regulating its dosage, the wrinkle removal effect is significantly improved. Specifically, the mass fraction of VEEGUM HS can be 1.0%, 3.0%, 5.0%, 8.0%, 10.0%, etc.; the mass fraction of sodium alginate can be 1.0%, 2.0%, 3.0%, 4.0%, 5.0%, etc. The particle size of sodium alginate can be 160 mesh-180 mesh for better dissolution and dispersion. Specifically, VEEGUM HS is magnesium aluminum silicate purchased from VANDERBILT MINERALS, LLC. Sodium alginate is a food-grade additive. In the embodiment of the present invention, it is used as a thickener in combination with VEEGUM HS to further enhance the instant wrinkle removal effect.

[0023] The moisturizer has a good moisturizing effect and prevents the skin from drying and peeling. The mass fraction of the moisturizer can be 1.000%, 2.000%, 3.000%, 4.000%, 5.000%, etc.

[0024] In some embodiments, the moisturizer includes: hexylene glycol 0.3%-1.0%, glycerol 0.1%-3.5%, GENENCARE@OSMS BA 0.1%-1.0% and macromolecular HA (hyaluronic acid) 0.001%-0.1%; wherein the molecular weight of macromolecular HA is 1.5-2 million and is purchased from Huaxi. By optimizing the composition of the moisturizer, hexylene glycol, glycerol, GENENCARE@OSMS BA and macromolecular HA play a good synergistic role and can effectively moisturize and prevent peeling.

[0025] Specifically, the mass fraction of hexylene glycol can be 0.3%, 0.5%, 0.8%, 1.0%, etc.; the mass fraction of glycerol can be 0.1%, 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, etc.; the mass fraction of GENENCARE@OSMS BA can be 0.1%, 0.3%, 0.5%, 0.8%, 1.0%, etc.; the mass fraction of macromolecular HA (hyaluronic acid) can be 0.001%, 0.005%, 0.010%, 0.050%, 0.100%, etc. GENENCARE@OSMS BA is betaine purchased from DANISCO.

[0026] The film-forming agent component enables the eye cream to have a good film-forming effect on the skin and play a long-lasting wrinkle-removing effect. The mass fraction of the film-forming agent can be 1.0%, 2.0%, 3.0%, 4.0%, 5.0%, 6.0%, 7.0%, 8.0%, etc. The film-forming agent can be PEPHA®-TIGHT CB, which can achieve an immediate and lasting skin firming and tightening effect, and better play a long-lasting wrinkle-removing and eye-bag-removing effect. PEPHA®-TIGHT CB is 3% NANNOCHLOROPSISOCULATA extract, 17.5% budding short pedunculate polysaccharide, 3% 1,2-pentanediol, 0.05 citric acid, 76.45% water, purchased from DSM Nutritional Products Ltd. PEPHA®-TIGHT has a good immediate and lasting skin-tightening effect, extracted from Nannochloropsis microalgae and natural polysaccharides.

[0027] The antioxidant component has a good antioxidant effect, further enhancing the long-lasting wrinkle removal effect. The mass fraction of the antioxidant component can be 0.2%, 0.3%, 0.5%, 0.8%, 1.0%, etc. The antioxidant component can be xinxian ketone, which can be combined with other components to further enhance the antioxidant effect.

[0028] The addition of auxiliary agents can further enhance the long-lasting wrinkle removal effect. The mass fraction of the auxiliary agents can be 5.00%, 8.00%, 10.00%, 13.00%, 15.00%, etc.

[0029] In some embodiments, the adjuvant includes: sodium silicate 0.1%-6%, PEG-40 hydrogenated castor oil 0.04%-2%, menthyl lactate 0.01%-0.5%, lactic acid 0.1%-6%, PERFELINE®-FIT 0.1%-5%, VETIVYNE 0.1%-3% and ADEKA MEVALONOLACTONE 0.01%-0.2%. By optimizing the type and amount of adjuvant, the long-term wrinkle removal effect is further enhanced.

[0030] Specifically, the mass fraction of sodium silicate can be 0.1%, 0.5%, 1.0%, 2.0%, 3.0%, 4.0%, 5.0%, 6.0%, etc.; the mass fraction of PEG-40 hydrogenated castor oil (Eumulgin® CO 40) can be 0.04%, 0.05%, 0.10%, 0.50%, 1.00%, 1.30%, 1.50%, 1.80%, 2.00%, etc.; the mass fraction of menthyl lactate (FRESCOLAT® ML The mass fraction of CRYST can be 0.01%, 0.05%, 0.10%, 0.20%, 0.30%, 0.40%, 0.50%, etc.; the mass fraction of lactic acid can be 0.1%, 0.5%, 1.0%, 2.0%, 3.0%, 4.0%, 5.0%, 6.0%, etc.; the mass fraction of PERFELINE®-FIT can be 0.1%, 0.5%, 1.0%, 2.0%, 3.0%, 4.0%, 5.0%, etc.; the mass fraction of VETIVYNE can be 0.1%, 0.5%, 1.0%, 2.0%, 3.0%, etc.; the mass fraction of ADEKA MEVALONOLACTONE can be 0.01%, 0.03%, 0.05%, 0.08%, 0.10%, 0.13%, 0.15%, 0.18%, 0.20%, etc.

[0031] Specifically, Eumulgin® CO 40 is PEG-40 hydrogenated castor oil, purchased from BASF. FRESCOLAT® MLCRYST is menthyl lactate, purchased from Dezhixin Flavors & Fragrances (Nantong Co., Ltd.). PERFELINE®-FIT is 50% water, 46.5% 1,3-propylene glycol, 3% Helichrysum angustifolium flower extract, 0.5% citric acid, purchased from RAHN AG. VETIVYNE is 50% 1,3-propylene glycol, 49.5% water, 0.5% vetiveria zinnia root extract, purchased from Givaudan Daily Flavors & Fragrances (Shanghai) Co., Ltd. ADEKA MEVALONOLACTONE is 99.7% mevalonolactone, 0.3% phenoxyethanol, purchased from Aidico (China) Investment Co., Ltd.

[0032] PERFELINE®-FIT has been used as a diuretic and as a powerful active ingredient to treat diseases related to edema. Using PERFELINE®-FIT in eye cream can reduce eye bags and make microcapillaries less noticeable. ADEKA MEVALONOLACTONE is a mevalonate lactone with the advantages of small molecules and easy penetration. It can promote the production of basal collagen and enhance the long-term wrinkle removal effect. VETIVYNE is extracted from the roots of Haitian vetiver (vetiver), rich in oleanolic acid, which can reactivate the synthesis of overall lipids in the skin and have the effect of smoothing and fading wrinkles.

[0033] In a preferred embodiment, the eye cream with long-term eye bag and wrinkle removal effects includes, by mass percentage: 50%-70% aqueous phase component, 10%-20% oil phase component, 5.0%-6.0% thickener component, 2.0%-3.0% moisturizer component, 2%-5% film former component, 0.3%-0.8% antioxidant component and 7.0%-9.0% auxiliary agent. By regulating the amount of aqueous phase component, oil phase component, thickener component, moisturizer component, film former component, antioxidant component and auxiliary agent, the prepared eye cream can better inhibit the activity of elastase, play a role in tightening the skin, and also have the effect of long-term eye bag removal.

[0034] In some embodiments, the eye cream also includes: pigment 0.02%-2.75%, preferably 0.15%-0.40%. By adding pigment, the eye cream product can be more closely matched to the skin color. The mass fraction of the pigment can be 0.02%, 0.05%, 0.10%, 0.15%, 0.20%, 0.30%, 0.40%, 0.50%, 1.00%, 1.50%, 2.00%, 2.50%, 2.75%, etc.

[0035] In a preferred embodiment, the pigment includes: 0.01%-1.5% red iron oxide (C33-8075) and 0.01%-1.25% yellow iron oxide (C33-8073). By adding red iron oxide and yellow iron oxide and accurately controlling the dosage, the eye cream product can be more suitable for the skin color of the eye area. Specifically, the mass fraction of red iron oxide (C33-8075) can be 0.01%, 0.05%, 0.10%, 0.30%, 0.50%, 0.80%, 1.00%, 1.20%, 1.50%, etc.

[0036] The embodiment of the present invention also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects, comprising: preparing ingredients according to the composition of the eye cream, and mixing the components. The mixing order is not limited, and a conventional mixing order can be used.

[0037] In some embodiments, the preparation method includes: firstly mixing water and a thickener component and heating them to obtain a first material; then mixing the first material with a moisturizer component and an antioxidant component, and then mixing with an auxiliary agent, an oil phase component, and a film former component to obtain a second material; and then mixing the second material with the ground pigment. By adjusting the order of mixing, the components can be more fully mixed and uniformly mixed, thereby improving the film-forming effect.

[0038] In a preferred embodiment, the preparation method comprises: (1) pretreatment: the pigment is mixed and ground with glycerin before adding, FRESCOLAT®ML CRYST (menthyl lactate) is dissolved with Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) before adding, and sodium silicate is dissolved with water before adding; (2) preparing the first material: mixing water and VEEGUM HS and heating them to 80°C-85°C, and then mixing them with sodium alginate; (3) preparing the second material: mixing the first material with glycerin, cinnamaldehyde, hexylene glycol, GENENCARE@OSMS BA, and macromolecular HA, and then mixing them with lactic acid, and then adding the dissolved sodium silicate and mixing them homogenously; cooling to 40°C-50°C, and then mixing with DOWSIL™ 9509 Silicone Elastomer Suspension, FRESCOLAT®ML CRYST (menthyl lactate) dissolved in Eumulgin® CO 40 (PEG-40 hydrogenated castor oil), and mixing them with DOWSIL™ 9509 Silicone Elastomer Suspension. CRYST (menthyl lactate), then mixed with PEPHA®-TIGHT CB, PERFELINE®-FIT, VETIVYNE, ADEKA MEVALONOLACTONE; (4) Mixing pigments: Mix the second material with the pigments that have been pre-ground with glycerin.

[0039] It should be noted that by first dissolving and grinding the components that are not easily dispersed, and adjusting the order of adding the raw materials, the uniformity of the prepared eye cream can be further improved, and the film-forming effect can be improved.

[0040] Specifically, the pigment is mixed and ground with glycerol during pretreatment, and the ratio of the two can be 1:1. The two pigments can be mixed and ground with glycerol separately, and the mass of glycerol added in the subsequent mixing is obtained by subtracting the grinding amount from the total amount of glycerol. The mixing temperature when preparing the first material can be 80°C, 83°C, 85°C, etc. The raw materials can be mixed evenly by high-speed homogenization, and the homogenization time can be 10min-20min. The homogenization time after adding sodium alginate can be 3min-10min; before adding DOWSIL™ 9509 Silicone Elastomer Suspension, the temperature can be lowered to 40°C, 45°C, 50°C, etc.

[0041] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.

[0042] Example 1 The present embodiment provides an eye cream with long-lasting eye bag and wrinkle removing effects, and the raw material composition is as follows: 65.03% of water phase component, 15% of oil phase component, 5.5% of thickener component, 3.05% of moisturizer component, 3% of film-forming agent component, 0.5% of antioxidant component, 7.65% of auxiliary agent, and 0.27% of pigment.

[0043] The composition of the aqueous phase: water 65.03%; Oil phase composition: DOWSIL™ 9509 Silicone Elastomer Suspension 15%; Thickener components: A: VEEGUM HS 3%; B: Sodium alginate (170 mesh) 2.5%; Moisturizer ingredients: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Film former composition: PEPHA®-TIGHT CB 3%; Antioxidant composition: Xinxianketone 0.5%; Auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: lactic acid 1%; E: PERFELINE®-FIT 3%; F: VETIVYNE 2%; G: ADEKA MEVALONOLACTONE 0.1%; Pigment composition A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (iron oxide yellow) 0.125%.

[0044] This embodiment also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this embodiment, and the preparation process refers to Example 1.

[0045] The results show that the eye cream system prepared in this example is stable and has a significant effect of instantly removing eye bags and wrinkles after application.

[0046] Example 2 The present embodiment provides an eye cream with long-lasting eye bag and wrinkle removing effects, and the raw material composition thereof is as follows: 64.03% of an aqueous phase component, 15% of an oil phase component, 5.5% of a thickener component, 3.05% of a moisturizer component, 3% of a film-forming agent component, 0.5% of an antioxidant component, 8.65% of an auxiliary agent, and 0.27% of a pigment.

[0047] The composition of the aqueous phase: water 64.03%; Oil phase composition: DOWSIL™ 9509 Silicone Elastomer Suspension 15%; Thickener components: A: VEEGUM HS 3%; B: Sodium alginate (170 mesh) 2.5%; Moisturizer ingredients: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Film former composition: PEPHA®-TIGHT CB 3%; Antioxidant composition: Xinxianketone 0.5%; Auxiliary components: A: Sodium silicate 1.8%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: Lactic acid 1.6%; E: PERFELINE®-FIT 3%; F: VETIVYNE 2%; G: ADEKA MEVALONOLACTONE 0.1%; Pigment composition: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (iron oxide yellow) 0.125%.

[0048] This embodiment also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this embodiment, and the preparation process refers to Example 1.

[0049] The results show that the eye cream system prepared in this example is stable. After application, the instant effect of removing eye bags and wrinkles is very significant, which is almost the same as the instant effect of removing eye bags and wrinkles in Example 2.

[0050] Example 3 The present embodiment provides an eye cream with long-lasting eye bag and wrinkle removing effects, and the raw material composition thereof is as follows: 17.95% of an aqueous phase component, 30% of an oil phase component, 15% of a thickener component, 5.6% of a moisturizer component, 5% of a film-forming agent component, 1% of an antioxidant component, 22.70% of an auxiliary agent, and 2.75% of a pigment.

[0051] The composition of the aqueous phase component: water 17.95%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 30%; Composition of thickener components: A: VEEGUM HS 10%; B: Sodium alginate (170 mesh) 5%; Composition of the moisturizer component: A: Hexanediol 1%; B: glycerol 3.5%; C: GENENCARE@OSMS BA 1.0%; D: Large molecule HA (1.5-2 million, Huaxi) 0.1%; Composition of the film former component: PEPHA®-TIGHT CB 5%; The composition of the antioxidant component: Xinxianketone 1%; Composition of auxiliary components: A: Sodium silicate 6%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 2%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.5%; D: Lactic acid 6%; E: PERFELINE®-FIT 5%; F: VETIVYNE 3%; G: ADEKA MEVALONOLACTONE 0.2%; Composition of pigment components: A: C33-8075 (iron oxide red) 1.5%; B: C33-8073 (iron oxide yellow) 1.25%.

[0052] This embodiment also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this embodiment, and the preparation process refers to Example 1.

[0053] The results showed that the eye cream prepared in this example had a serious whitening phenomenon and was highly irritating when applied.

[0054] Example 4 The present embodiment provides an eye cream with long-lasting eye bag and wrinkle removing effects, and the raw material composition thereof is as follows: 50.03% of an aqueous phase component, 30% of an oil phase component, 5.5% of a thickener component, 3.05% of a moisturizer component, 3% of a film former component, 0.5% of an antioxidant component, 7.65% of an auxiliary agent, and 0.27% of a pigment.

[0055] The composition of the aqueous phase: water 50.03%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 30%; Composition of thickener components: A: VEEGUM HS 3%; B: Sodium alginate (170 mesh) 2.5%; Composition of the moisturizer component: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Composition of the film former component: PEPHA®-TIGHT CB 3%; The composition of the antioxidant component: 0.5% xinxian ketone; Composition of auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: lactic acid 1%; E: PERFELINE®-FIT 3%; F: VETIVYNE 2%; G: ADEKA MEVALONOLACTONE 0.1%; Composition of pigment components: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (iron oxide yellow) 0.125%.

[0056] This embodiment also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this embodiment, and the preparation process refers to Example 1.

[0057] The results show that the eye cream system prepared in this example is stable. After application, the effect of instantly removing eye bags and wrinkles is similar to that of Example 2, but it is easy to rub into mud.

[0058] Example 5 The present embodiment provides an eye cream with long-lasting eye bag and wrinkle removing effects, and the raw material composition is as follows: 75.03% of water phase component, 5% of oil phase component, 5.5% of thickener component, 3.05% of moisturizer component, 3% of film-forming agent component, 0.5% of antioxidant component, 7.65% of auxiliary agent and 0.27% of pigment.

[0059] The composition of the aqueous phase: water 75.03%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 5%; Composition of thickener components: A: VEEGUM HS 3%; B: Sodium alginate (170 mesh) 2.5%; Composition of the moisturizer component: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Composition of the film former component: PEPHA®-TIGHT CB 3%; The composition of the antioxidant component: 0.5% xinxian ketone; Composition of auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: lactic acid 1%; E: PERFELINE®-FIT 3%; F: VETIVYNE 2%; G: ADEKA MEVALONOLACTONE 0.1%; Composition of pigment components: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (iron oxide yellow) 0.125%.

[0060] This embodiment also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this embodiment, and the preparation process refers to Example 1.

[0061] The results show that the eye cream system prepared in this example is stable, and after application, the effect of instantly removing eye bags and wrinkles is not as good as that of Example 2.

[0062] Example 6 This comparative example provides an eye cream, whose raw material composition is as follows: 64.93% of water phase component, 15% of oil phase component, 5.5% of thickener component, 3.05% of moisturizer component, 3% of film-forming agent component, 0.5% of antioxidant component, 7.75% of auxiliary agent and 0.27% of pigment.

[0063] The composition of the aqueous phase: water 64.93%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 15%; Composition of thickener components: A: VEEGUM HS 3%; B: Sodium alginate (170 mesh) 2.5%; Composition of the moisturizer component: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Composition of the film former component: PEPHA®-TIGHT CB 3%; The composition of the antioxidant component: 0.5% xinxian ketone; Composition of auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.2%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.05%; D: lactic acid 1%; E: PERFELINE®-FIT 3%; F: VETIVYNE 2%; G: ADEKA MEVALONOLACTONE 0.1%; Composition of pigment components: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (iron oxide yellow) 0.125%.

[0064] This comparative example also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this example, and the preparation process refers to Example 1.

[0065] The results showed that the eye cream prepared in this comparative example had a too strong cooling sensation and was irritating.

[0066] Comparative Example 1 (Comparative Example 1 mainly changes the type of thickener compared to Example 2) This comparative example provides an eye cream, whose raw material composition is as follows: 64.73% of water phase component, 15% of oil phase component, 5.8% of thickener component, 3.05% of moisturizer component, 3% of film-forming agent component, 0.5% of antioxidant component, 7.65% of auxiliary agent and 0.27% of pigment.

[0067] Composition of the aqueous phase: water 64.73%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 15%; Composition of the thickener component: VEEGUM HV (magnesium aluminum silicate) 5.8%; Composition of the moisturizer component: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Composition of the film former component: PEPHA®-TIGHT CB 3%; The composition of the antioxidant component: 0.5% xinxian ketone; Composition of auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: lactic acid 1%; E: PERFELINE®-FIT 3%; F: VETIVYNE 2%; G: ADEKA MEVALONOLACTONE 0.1%; Composition of pigment components: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (iron oxide yellow) 0.125%.

[0068] This embodiment also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this embodiment. The preparation process is as follows: (1) Grind glycerin and C33-8075 (iron oxide red) and grind glycerin and C33-8073 (iron oxide yellow) in a ratio of 1:1, dissolve FRESCOLAT® ML CRYST (menthyl lactate) in Eumulgin® CO 40 (PEG-40 hydrogenated castor oil), and dissolve sodium silicate in hot water.

[0069] (2) Add water first, then add VEEGUM HV, heat to 80-85℃, and homogenize at high speed for 15 minutes.

[0070] (3) Add glycerin, phenoxyethanol, 1,2-hexanediol, GENENCARE@OSMS BA, and macromolecular HA (1.5-2 million, Huaxi), stir evenly, add lactic acid, stir evenly, add sodium silicate dissolved in hot water in advance, homogenize for 5 minutes, stir evenly, and cool down.

[0071] (4) Cool down to 45°C, add DOWSIL™ 9509 Silicone Elastomer Suspension, stir well, add FRESCOLAT®ML CRYST (menthyl lactate) dissolved in Eumulgin® CO 40 (PEG-40 hydrogenated castor oil), stir well, then add PEPHA®-TIGHT CB, PERFELINE®-FIT, VETIVYNE, stir well, add ADEKA MEVALONOLACTONE, stir well, add pre-ground glycerin and C33-8075 (iron oxide red) in a ratio of 1:1 and pre-ground glycerin and C33-8073 (iron oxide yellow) in a ratio of 1:1, stir well.

[0072] The results show that the eye cream system prepared in this comparative example is not very stable and has water release, and the instant effect of the product in removing eye bags and wrinkles needs to be enhanced.

[0073] Comparative Example 2 (Comparative Example 2 mainly changes the type and amount of thickener relative to Example 2) This comparative example provides an eye cream, whose raw material composition is as follows: 63.28% of water phase component, 15% of oil phase component, 7.25% of thickener component, 3.05% of moisturizer component, 3% of film former component, 0.5% of antioxidant component, 7.65% of auxiliary agent and 0.27% of pigment.

[0074] The composition of the aqueous phase is: water 63.28%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 15%; Composition of thickener components: A: VEEGUM HV 6.5%; B: BETONE BW 0.5%; C: Opaque xanthan gum 0.25%; Composition of the moisturizer component: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Composition of the film former component: PEPHA®-TIGHT CB 3%; The composition of the antioxidant component: 0.5% xinxian ketone; Composition of auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: lactic acid 1%; E: PERFELINE®-FIT 3%; F: VETIVYNE 2%; G: ADEKA MEVALONOLACTONE 0.1%; Composition of pigment components: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (iron oxide yellow) 0.125%.

[0075] This comparative example also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this example, and the preparation process refers to Example 1.

[0076] The results showed that the eye cream system prepared in this comparative example was not very stable, had water leakage, and had serious whitening phenomenon when applied.

[0077] Comparative Example 3 (Comparative Example 3 mainly changes the composition of the moisturizer compared to Example 2) This comparative example provides an eye cream, whose raw material composition is as follows: 67.58% of water phase component, 15% of oil phase component, 5.5% of thickener component, 0.5% of moisturizer component, 3% of film-forming agent component, 0.5% of antioxidant component, 7.65% of auxiliary agent and 0.27% of pigment.

[0078] The composition of the aqueous phase is: water 63.48%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 15%; Composition of thickener components: A: VEEGUM HS 3%; B: Sodium alginate (170 mesh) 2.5%; Composition of the moisturizer component: A: Hexanediol 0.5%; B: glycerol 0%; C: GENENCARE@OSMS BA 0%; D: Large molecule HA (1.5-2 million, Huaxi) 0%; Composition of the film former component: PEPHA®-TIGHT CB 3%; The composition of the antioxidant component: 0.5% xinxian ketone; Composition of auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: lactic acid 1%; E: PERFELINE®-FIT 3%; F: VETIVYNE 2%; G: ADEKA MEVALONOLACTONE 0.1%; Composition of pigment components: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (yellow iron oxide) 0.125%.

[0079] This comparative example also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this example, and the preparation process refers to Example 1.

[0080] The results show that the eye cream system prepared in this comparative example is stable. After application, it has a very significant effect of instantly removing eye bags and wrinkles, but it is prone to peeling.

[0081] Comparative Example 4 (the difference between Comparative Example 4 and Example 2 is that no film-forming agent component is added) This comparative example provides an eye cream, whose raw material composition is as follows: 68.03% of water phase component, 15% of oil phase component, 5.5% of thickener component, 3.05% of moisturizer component, 0% of film-forming agent component, 0.5% of antioxidant component, 7.65% of auxiliary agent and 0.27% of pigment.

[0082] The composition of the aqueous phase is: water 68.03%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 15%; Composition of thickener components: A: VEEGUM HS 3%; B: Sodium alginate (170 mesh) 2.5%; Composition of the moisturizer component: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Composition of the film former component: PEPHA®-TIGHT CB 0%; The composition of the antioxidant component: 0.5% xinxian ketone; Composition of auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: lactic acid 1%; E: PERFELINE®-FIT 3%; F: VETIVYNE 2%; G: ADEKA MEVALONOLACTONE 0.1%; Composition of pigment components: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (iron oxide yellow) 0.125%.

[0083] This comparative example also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this example, and the preparation process refers to Example 1.

[0084] The results show that the eye cream system prepared in this comparative example is stable, and after application, the effect of instantly removing eye bags and wrinkles is not as significant as that in Example 2.

[0085] Comparative Example 5 (the main difference between Comparative Example 5 and Example 2 is that the amount and composition of the auxiliary agent are changed) This comparative example provides an eye cream, whose raw material composition is as follows: 68.03% of water phase component, 15% of oil phase component, 5.5% of thickener component, 3.05% of moisturizer component, 3% of film former component, 0.5% of antioxidant component, 4.65% of auxiliary agent and 0.27% of pigment.

[0086] The composition of the aqueous phase is: water 68.03%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 15%; Composition of thickener components: A: VEEGUM HS 3%; B: Sodium alginate (170 mesh) 2.5%; Composition of the moisturizer component: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Composition of the film former component: PEPHA®-TIGHT CB 3%; The composition of the antioxidant component: 0.5% xinxian ketone; Composition of auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: lactic acid 1%; E: PERFELINE®-FIT 0%; F: VETIVYNE 2%; G: ADEKA MEVALONOLACTONE 0.1%; Composition of pigment components: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (yellow iron oxide) 0.125%.

[0087] This comparative example also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this example, and the preparation process refers to Example 1.

[0088] The results show that the eye cream system prepared in this comparative example is stable. After application, it has a very significant effect in instantly removing eye bags and wrinkles, but its long-term effect in removing eye bags is poor.

[0089] Comparative Example 6 (the main difference between Comparative Example 6 and Example 2 is that the amount and composition of the auxiliary agent are changed) This comparative example provides an eye cream, whose raw material composition is as follows: 67.03% of water phase component, 15% of oil phase component, 5.5% of thickener component, 3.05% of moisturizer component, 3% of film-forming agent component, 0.5% of antioxidant component, 5.65% of auxiliary agent and 0.27% of pigment.

[0090] The composition of the aqueous phase is: water 67.03%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 15%; Composition of thickener components: A: VEEGUM HS 3%; B: Sodium alginate (170 mesh) 2.5%; Composition of the moisturizer component: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Composition of the film former component: PEPHA®-TIGHT CB 3%; The composition of the antioxidant component: 0.5% xinxian ketone; Composition of auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: lactic acid 1%; E: PERFELINE®-FIT 3%; F: VETIVYNE 0%; G: ADEKA MEVALONOLACTONE 0.1%; Composition of pigment components: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (iron oxide yellow) 0.125%.

[0091] This comparative example also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this example, and the preparation process refers to Example 1.

[0092] The results show that the eye cream system prepared in this comparative example is stable. After application, it has a very significant effect in instantly removing eye bags and wrinkles, but the long-term effect in removing eye bags is not good.

[0093] Comparative Example 7 (the main difference between Comparative Example 7 and Example 2 is that the amount and composition of the auxiliary agent are changed) This comparative example provides an eye cream, whose raw material composition is as follows: 65.13% of water phase component, 15% of oil phase component, 5.5% of thickener component, 3.05% of moisturizer component, 3% of film-forming agent component, 0.5% of antioxidant component, 7.55% of auxiliary agent and 0.27% of pigment.

[0094] The composition of the aqueous phase is: water 65.13%; Composition of the oil phase component: DOWSIL™ 9509 Silicone Elastomer Suspension 15%; Composition of thickener components: A: VEEGUM HS 3%; B: Sodium alginate (170 mesh) 2.5%; Composition of the moisturizer component: A: Hexanediol 0.5%; B: glycerol 2%; C: GENENCARE@OSMS BA 0.5%; D: Large molecule HA (1.5-2 million, Huaxi) 0.05%; Composition of the film former component: PEPHA®-TIGHT CB 3%; The composition of the antioxidant component: 0.5% xinxian ketone; Composition of auxiliary components: A: Sodium silicate 1.4%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.12%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.03%; D: lactic acid 1%; E: PERFELINE®-FIT 3%; F: VETIVYNE 2%; G:ADEKA MEVALONOLACTONE 0%; Composition of pigment components: A: C33-8075 (iron oxide red) 0.145%; B: C33-8073 (yellow iron oxide) 0.125%.

[0095] This comparative example also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this example, and the preparation process refers to Example 1.

[0096] The results show that the eye cream system prepared in this comparative example is stable, and after application, the effect of instantly removing eye bags and wrinkles is very significant.

[0097] Comparative Example 8 The only difference from Example 2 is that the thickener component is a single VEEGUM HS, and the dosage is 5.5%. The other components are consistent with Example 2.

[0098] Comparative Example 9 The only difference from Example 2 is that the thickener component is a single sodium alginate (170 mesh), and its dosage is 5.5%, and the other components are consistent with Example 2.

[0099] Comparative Example 10 The only difference from Example 2 is that the VEEGUM HS in the thickener component is replaced by an equal amount of VEEGUM HV, and the system is unstable and water is released.

[0100] Comparative Example 11 The only difference from Example 2 is that the film-forming agent component is replaced by an equal amount of polystyrene sulfonate sodium salt FLEXAN II.

[0101] Comparative Example 12 The only difference from Example 2 is that the oil phase component is replaced by an equal amount of DOWSIL FB-9586 silicone elastomer mixture.

[0102] Comparative Example 13 The only difference from Example 2 is that the total amount of the auxiliary agent remains unchanged, and the specific composition and amount are changed as follows: 1% sodium silicate, 1.4% lactic acid, and the other components are consistent with Example 2.

[0103] Comparative Example 14 This comparative example provides an eye cream with long-lasting eye bag and wrinkle removal effects, the raw material composition of which is as follows: 95.219% of water phase component, 1% of oil phase component, 2% of thickener component, 0.501% of moisturizer component, 0.5% of film former component, 0.3% of antioxidant component, 0.46% of auxiliary agent and 0.02% of pigment; The composition of the aqueous phase: water 95.219%; Oil phase composition: DOWSIL™ 9509 Silicone Elastomer Suspension 1%; Thickener components: A: VEEGUM HS 1%; B: Sodium alginate (170 mesh) 1%; Moisturizer ingredients: A: Hexanediol 0.3%; B: glycerol 0.1%; C: GENENCARE@OSMS BA 0.1%; D: Large molecule HA (1.5-2 million, Huaxi) 0.001%; Film former component composition: PEPHA®-TIGHT CB 0.5%; Antioxidant composition: Xinxianketone 0.3% Auxiliary components: A: Sodium silicate 0.1%; B: Eumulgin® CO 40 (PEG-40 hydrogenated castor oil) 0.04%; C: FRESCOLAT®ML CRYST (menthyl lactate) 0.01%; D: lactic acid 0.1%; E: PERFELINE®-FIT 0.1%; F: VETIVYNE 0.1%; G: ADEKA MEVALONOLACTONE 0.01%; Pigment composition A: C33-8075 (iron oxide red) 0.01%; B: C33-8073 (iron oxide yellow) 0.01%.

[0104] This embodiment also provides a method for preparing an eye cream with long-lasting eye bag and wrinkle removing effects. The ingredients are prepared according to the composition of the eye cream provided in this embodiment. The preparation process is as follows: (1) Grind glycerol and C33-8075 (iron oxide red) and grind glycerol and C33-8073 (iron oxide yellow) in a ratio of 1:1, dissolve FRESCOLAT®ML CRYST (menthyl lactate) in Eumulgin®CO 40 (PEG-40 hydrogenated castor oil) (heated to 45-50°C), and dissolve sodium silicate in hot water (50°C). The mass ratio of hot water to sodium silicate is 5:1.

[0105] (2) First add water, then add VEEGUM HS, heat to 85°C, homogenize at high speed for 15 minutes, then add sodium alginate and homogenize for 5 minutes.

[0106] (3) Add glycerin, phenoxyethanol, 1,2-hexanediol, GENENCARE@OSMS BA, and macromolecular HA (1.5-2 million, Huaxi), stir evenly, add lactic acid, stir evenly, add sodium silicate dissolved in hot water in advance, homogenize for 5 minutes, stir evenly, and cool down.

[0107] (4) Cool down to 45°C, add DOWSIL™ 9509 Silicone Elastomer Suspension, stir evenly, add FRESCOLAT®ML CRYST (menthyl lactate) dissolved in Eumulgin®CO 40 (PEG-40 hydrogenated castor oil) (heated to 45-50°C), stir evenly, then add PEPHA®-TIGHT CB, PERFELINE®-FIT, VETIVYNE, ADEKA MEVALONOLACTONE, stir evenly, add pre-ground glycerin and C33-8075 (iron oxide red) in a ratio of 1:1 and pre-ground glycerin and C33-8073 (iron oxide yellow) in a ratio of 1:1, stir evenly.

[0108] The results show that the eye cream system prepared in this comparative example is stable, and after application, the effect of immediately removing eye bags and wrinkles is not obvious.

[0109] Test Example 1 The use effect of the eye cream prepared in the test example and the comparative example is as follows: (1) Remove wrinkles and eye bags immediately: Take an appropriate amount with your fingertips and pat gently around the eyes after cleansing. The film will dry off within three minutes, achieving the purpose of immediate wrinkle and eye bag removal with significant results.

[0110] Test method: This experiment randomly selected 400 volunteers and divided them into 20 groups (the volunteers did not apply the product to their left eyes, and applied the products of Examples 1-6 and Comparative Examples 1-14 to their right eyes), aged between 30 and 50 years old. The total score of each effect is 10 points, and the following is the average score of each item. The scores of each group are shown in Table 1.

[0111] Table 1 Comparison of instant firming effects of the examples and comparative examples

[0112] (2) Long-term effect of removing eye bags: Apply the cosmetic formula to the eyes twice a day for 28 days. VISIA was used to evaluate before and on the 28th day after application.

[0113] The reduction in eye bag volume compared with the initial value is shown in Table 2.

[0114] Table 2 Long-term effect of removing eye bags

[0115] Test Example 2 The anti-wrinkle effect of the eye cream prepared in the test examples and comparative examples is as follows: (1) Test principle: As a highly selective and specific protease, elastase catalyzes the hydrolysis of many amino acids such as glycine, leucine, alanine and other hydroxyl-containing polypeptide bonds, and can decompose elastin in connective tissue protein. Inhibiting the activity of elastase can effectively slow down the degradation of elastin and play a role in tightening the skin. This experiment uses Congo red-elastin as the substrate. After porcine pancreatic elastase hydrolyzes elastin, Congo red dye falls off into the solution. At this time, the solution appears red. When the enzyme inhibition sample is added, the enzyme activity is inhibited, the red color becomes lighter, and the inhibition ability is negatively correlated with the depth of the red. The inhibition rate can be indirectly obtained by measuring the absorbance at 405nm using a UV-visible spectrophotometer. This test method is an in vitro method and is suitable for the detection of the anti-wrinkle effect of cosmetics of various matrix types.

[0116] (2) Test method: Determination of elastase inhibition rate: Add 90 μL buffer, 30 μL sample diluent of different concentrations and 10 μL substrate to a 96-well plate, mix well and incubate at 25°C for 20 minutes. Then add 20 μL elastase solution, shake and mix immediately and detect OD405nm, incubate for 10 minutes and detect OD405nm again to obtain the effect of the sample on the activity of elastase.

[0117] The test results are shown in Table 3: Table 3 Anti-wrinkle effect of eye cream prepared in Examples and Comparative Examples

[0118] In summary, the instant eye bag and wrinkle removing eye cream provided by the present invention can achieve a good on-site demonstration effect, and can also be used in special occasions to make oneself look younger. The product is safe and reliable.

[0119] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. An eye cream with long-lasting eye bag and wrinkle removal effects, characterized in that: In terms of mass percentage, it includes: 40%-80% water phase component, 5%-30% oil phase component, 3%-10% thickener component, 1.0%-5.0% moisturizer component, 1%-8% film former component, 0.2%-1.0% antioxidant component and 5.0%-15.0% auxiliary agent; Wherein, the oil phase component is a silicone elastomer suspension DOWSIL™ 9509 Silicone ElastomerSuspension; The thickener component includes 1%-10% of magnesium aluminum silicate and 1%-5% of sodium alginate.

2. The eye cream according to claim 1, characterized in that In terms of mass percentage, it includes: 50%-70% water phase component, 10%-20% oil phase component, 5.0%-6.0% thickener component, 2.0%-3.0% moisturizer component, 2%-5% film former component, 0.3%-0.8% antioxidant component and 7.0%-9.0% auxiliary agent; The thickener component includes 2%-4% magnesium aluminum silicate and 1.0%-4.0% sodium alginate; The aqueous phase component is water.

3. The eye cream according to claim 1 or 2, characterized in that: The moisturizer includes: hexylene glycol 0.3%-1.0%, glycerin 0.1%-3.5%, betaine 0.1%-1.0% and macromolecular HA 0.001%-0.1%; Wherein, the molecular weight of the macromolecular HA is 1.5-2 million.

4. The eye cream according to claim 1 or 2, characterized in that: The film former is PEPHA®-TIGHT CB.

5. The eye cream according to claim 1 or 2, characterized in that: The antioxidant component is cinnamon.

6. The eye cream according to claim 1 or 2, characterized in that: The auxiliary agents include: sodium silicate 0.1%-6%, PEG-40 hydrogenated castor oil 0.04%-2%, menthyl lactate 0.01%-0.5%, lactic acid 0.1%-6%, PERFELINE®-FIT 0.1%-5%, VETIVYNE 0.1%-3% and ADEKA MEVALONOLACTONE 0.01%-0.2%.

7. The eye cream according to claim 1 or 2, characterized in that: Also includes: Pigment 0.02%-2.75%; The pigment comprises: 0.01%-1.5% of red iron oxide and 0.01%-1.25% of yellow iron oxide.

8. A method for preparing the eye cream according to any one of claims 1 to 7, characterized in that: include: The ingredients are prepared according to the composition of the eye cream and the components are mixed.

9. The preparation method according to claim 8, characterized in that: include: Firstly, water and the thickener component are mixed and heated to obtain a first material; the first material is mixed with the moisturizer component and the antioxidant component, and then mixed with the auxiliary agent, the oil phase component and the film-forming agent component to obtain a second material; the second material is mixed with the ground pigment.

10. The preparation method according to claim 9, characterized in that: include: Pretreatment: the pigments are mixed and ground with glycerin before adding, menthyl lactate is dissolved with PEG-40 hydrogenated castor oil before adding, and sodium silicate is dissolved with water before adding; Prepare the first material: mix water and magnesium aluminum silicate and heat to 80°C-85°C, then mix with sodium alginate and homogenize; Preparation of the second material: mixing the first material with glycerin, cinnamaldehyde, hexylene glycol, betaine, and macromolecular HA, then mixing with lactic acid, and then adding dissolved sodium silicate to mix homogeneously; cooling to 40°C-50°C, then mixing with DOWSIL™9509 Silicone Elastomer Suspension and menthyl lactate pre-dissolved with PEG-40 hydrogenated castor oil, and then mixing with PEPHA®-TIGHT CB, PERFELINE®-FIT, VETIVYNE, and ADEKA MEVALONOLACTONE; Mixing pigment: Mix the second material with the pigment that has been pre-ground with glycerin.

Images